DLD Asset Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-94,853
Closed -$1M 489
2026
Q1
$1M Hold
94,853
0.09% 162
2025
Q4
$995K Hold
94,853
0.07% 193
2025
Q3
$982K Sell
94,853
-100,000
-51% -$1.03M 0.07% 176
2025
Q2
$2M Hold
194,853
0.17% 98
2025
Q1
$1.96M Buy
+194,853
New +$1.96M 0.15% 72

Other funds holding TDAC

DLD Asset Management's TDAC Position: Q2 2026 in Review

DLD Asset Management sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 94,853 shares — an estimated $1M sold.

DLD Asset Management first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $2M in Q2 2025. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • DLD Asset Management reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • DLD Asset Management sold 94,853 Translational Development Acquisition Corp shares in Q2 2026, an estimated $1M.
  • DLD Asset Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • DLD Asset Management's Translational Development Acquisition Corp position peaked at $2M in Q2 2025.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.